# Takeda ends DNL593 collaboration; Denali regains full rights

- slug: takeda-ends-dnl593-collaboration-denali-regains-full-rights
- date: 2026-04-06
- category: Biotech & Life Sciences

Takeda terminated its DNL593 partnership for strategic reasons, not safety. Denali regains full rights. The Phase 1/2 trial continues with 40 patients and data due end of 2026.

---